Role of Angiogenesis and Its Biomarkers in Development of Targeted Tumor Therapies

Figure 5

Antiangiogenic drugs and their targets such as VEGF, PDGF, EGF, and ANGPT2 along with biological substrates and respective inhibitors available in the market.